Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer, Clinical Trials

Eric Van Cutsem

MD, PhD

🏢University Hospitals Leuven🌐Belgium

Professor of Internal Medicine, Head of Digestive Oncology

130
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Eric Van Cutsem is a preeminent gastrointestinal oncologist who has led numerous practice-changing colorectal cancer trials in Europe. He contributed to the development of cetuximab, panitumumab, regorafenib, and fruquintinib for metastatic disease. He co-chaired the BEACON and FRESCO-2 trials.

Share:

🧪Research Fields 研究领域

metastatic CRC
EGFR antibodies
angiogenesis inhibitors
European CRC trials
regorafenib

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Eric Van Cutsem 的研究动态

Follow Eric Van Cutsem's research updates

留下邮箱,当我们发布与 Eric Van Cutsem(University Hospitals Leuven)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment